- Home
- MRKR vs LIQT Comparison
MRKR vs LIQT Comparison
Compare MRKR & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- LIQT
- Stock Information
- Founded
- MRKR N/A
- LIQT 2004
- Country
- MRKR United States
- LIQT Denmark
- Employees
- MRKR N/A
- LIQT N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- LIQT Industrial Machinery/Components
- Sector
- MRKR Health Care
- LIQT Technology
- Exchange
- MRKR Nasdaq
- LIQT Nasdaq
- Market Cap
- MRKR 19.1M
- LIQT 16.1M
- IPO Year
- MRKR N/A
- LIQT N/A
- Fundamental
- Price
- MRKR $1.47
- LIQT $1.70
- Analyst Decision
- MRKR Strong Buy
- LIQT Strong Buy
- Analyst Count
- MRKR 3
- LIQT 2
- Target Price
- MRKR $13.17
- LIQT $4.80
- AVG Volume (30 Days)
- MRKR 231.4K
- LIQT 15.5K
- Earning Date
- MRKR 08-13-2025
- LIQT 08-13-2025
- Dividend Yield
- MRKR N/A
- LIQT N/A
- EPS Growth
- MRKR N/A
- LIQT N/A
- EPS
- MRKR N/A
- LIQT N/A
- Revenue
- MRKR $5,696,123.00
- LIQT $14,986,815.00
- Revenue This Year
- MRKR N/A
- LIQT $36.89
- Revenue Next Year
- MRKR $11.28
- LIQT $16.33
- P/E Ratio
- MRKR N/A
- LIQT N/A
- Revenue Growth
- MRKR 71.53
- LIQT N/A
- 52 Week Low
- MRKR $0.95
- LIQT $1.34
- 52 Week High
- MRKR $5.99
- LIQT $3.20
- Technical
- Relative Strength Index (RSI)
- MRKR 50.81
- LIQT 52.96
- Support Level
- MRKR $1.41
- LIQT $1.58
- Resistance Level
- MRKR $1.53
- LIQT $1.64
- Average True Range (ATR)
- MRKR 0.16
- LIQT 0.09
- MACD
- MRKR -0.03
- LIQT -0.01
- Stochastic Oscillator
- MRKR 9.43
- LIQT 44.83
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.